Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs2
POTELIGEO
(mogamulizumab)Orphan drugstandardKyowa Kirin Pharmaceutical Development Inc.
Chemokine Receptor Type 4 Interaction [EPC]
12.1 Mechanism of Action Mogamulizumab-kpkc is a defucosylated, humanized IgG1 kappa monoclonal antibody that binds to CCR4, a G protein-coupled recep...
Nplate
(ROMIPLOSTIM)Orphan drugstandardAmgen, Inc
Thrombopoietin Receptor Agonist [EPC]
12.1 Mechanism of Action Nplate increases platelet production through binding and activation of the TPO receptor, a mechanism analogous to endogenous ...